CORI

The CORI Surgical System is Smith+Nephew's compact, surgeon-controlled handheld robotics platform for orthopedic knee surgery, recorded in the surgical form factor as the handheld, imageless, smaller-footprint archetype of the orthopedic sub-cohort. Unlike Stryker's Mako, which uses a pre-operative CT scan and a large robotic arm, CORI is imageless: the surgeon paints the joint surface intra-operatively to build a three-dimensional bone model, then uses a handheld robotic bur whose cutting speed and exposure are robotically controlled to the surgical plan, with optical navigation via a passive infrared camera that Smith+Nephew states is four times faster with twice the cutting volume of the prior NAVIO system. Because the surgeon physically holds and moves the tool throughout while the software does the imageless mapping, planning, and intra-operative tracking that governs the bur, CORI is AI-augmented surgeon-controlled assistance and not autonomous, and it is in scope as a surgical robot. Made by Smith+Nephew, listed as SN in London and SNN in New York, the system descends from Smith+Nephew's October 2015 acquisition of Blue Belt Technologies for 275 million dollars, whose NAVIO handheld system evolved into CORI at its July 14, 2020 launch alongside the Real Intelligence platform. Its robotic-cutting scope is cleared for total, partial or unicompartmental, and revision knee, with revision knee a 2022 first-to-market indication on a robotics platform; its hip capability is navigation only, through RI.HIP NAVIGATION cleared in January 2022, and is not robotic burring, a distinction several secondary sources blur. The platform is positioned for ambulatory surgery centers and outpatient operating rooms, and no CORI-specific installed-base or procedure-volume figure is asserted here because none was verified against Smith+Nephew investor disclosure.

CORI is listed at $600,000 to $1,200,000 on the DEPLOY registry. This is an analyst estimate, not an official price.

Yes. CORI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Not verified as fully autonomous. CORI's capabilities on the DEPLOY registry are recorded as teleoperated-assisted, demonstrated-only, or vendor claims (Assists surgery), not independently confirmed to run without a human in the loop.

CORI is made by Smith+Nephew, based in Watford, England, UK, founded in 1856.

1 verified deployment of CORI is on the DEPLOY registry, including at United States.

CORI is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

CORI has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance, cleared. See the Regulatory filings section for each agency source.

On the DEPLOY registry, comparable surgical robots to CORI include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

CORI and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. CORI has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, CORI ranks in roughly the top 49% of surgical models tracked by the registry.

CORI is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

CORI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

The Smith Nephew CORI Surgical System is a handheld robotic platform for orthopedic surgery, designed for accuracy in bone resection and alignment. It is the first system indicated for robotic-assisted revision knee surgery. The CORI XT is the next-generation platform for all orthopedic needs from partial to revision knee, hip, and shoulder.